Literature DB >> 9296410

Use of alfentanil and propofol for outpatient monitored anesthesia care: determining the optimal dosing regimen.

M N Avramov1, P F White.   

Abstract

UNLABELLED: Propofol and alfentanil are both rapid and short-acting drugs that can be used for sedation and analgesia during monitored anesthesia care (MAC). This study was designed to determine the optimal infusion rates of propofol and alfentanil when administered during local anesthesia. In this randomized, double-blind study, we evaluated the effects of different propofol infusion rates on the alfentanil requirement, level of sedation, intraoperative recall, respiratory and cardiovascular variables, and recovery. Seventy-two consenting ASA physical status I or II female outpatients undergoing breast biopsy procedures with local anesthesia were randomly assigned to one of four treatment groups. All patients received midazolam, 2 mg intravenously (I.V.) for premedication. Propofol was infused at 0, 25, 50, or 75 microg x kg(-1) x min(-1) during the operation. Sedation was evaluated using the Observer's Assessment of Alertness/Sedation (OAA/S) scale at 5-min intervals by a blinded observer. Two minutes before the infiltration of the local anesthetic solution, a bolus of alfentanil, 2.5 microg/kg I.V., was administered, followed by a maintenance infusion of 0.5 microg x kg(-1) x min(-1). The alfentanil infusion rate was subsequently varied to maintain patient comfort and stable cardiovascular and respiratory function. Pictures were shown at the start of the propofol infusion, upon initiating the alfentanil infusion, and at 45 min after the skin incision to evaluate recall of intraoperative events. Propofol produced dose-dependent increases in the level of sedation (with median OAA/S scores of 2-4, P < 0.05). Higher infusion rates of propofol (50-75 microg x kg(-1) x min(-1)) produced significant amnesia, opioid-sparing effects (alfentanil 0.3 +/- 0.2 vs 0.6 +/- 0.2 microg x kg(-1) x min(-1)), and less postoperative nausea and vomiting (P < 0.05). However, episodes of transient hemoglobin oxygen desaturation were more common in the deeply sedated patients. Thus, in healthy outpatients premedicated with midazolam, 2 mg I.V., a propofol infusion of 25-50 microg x kg(-1) x min(-1) in combination with an alfentanil infusion of 0.2-0.4 microg x kg(-1) x min(-1) is recommended for sedation and analgesia during MAC in the ambulatory setting. IMPLICATIONS: Sedation is often given during local anesthesia. This study demonstrated that administration of an intravenous anesthetic, propofol, in combination with an opioid infusion (i.e., alfentanil) to provide sedation analgesia and amnesia with a low incidence of side effects, such as nausea and vomiting and respiratory depression in outpatients premedicated with midazolam.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296410     DOI: 10.1097/00000539-199709000-00015

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.

Authors:  Talmage D Egan; Shinju Obara; Thomas E Jenkins; Sarah S Jaw-Tsai; Shanti Amagasu; Daniel R Cook; Scott C Steffensen; David T Beattie
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

2.  Dexmedetomidine is effective for monitored anesthesia care in outpatients undergoing cataract surgery.

Authors:  Hyo-Seok Na; In-Ae Song; Hong-Sik Park; Jung-Won Hwang; Sang-Hwan Do; Chong-Soo Kim
Journal:  Korean J Anesthesiol       Date:  2011-12-20

3.  Direct visualization of general anesthetic propofol on neurons by stimulated Raman scattering microscopy.

Authors:  Robert Oda; Jingwen Shou; Wenying Zhong; Yasuyuki Ozeki; Masato Yasui; Mutsuo Nuriya
Journal:  iScience       Date:  2022-02-17

4.  Moderate sedation by total intravenous remimazolam-alfentanil vs. propofol-alfentanil for third molar extraction: A prospective randomized controlled trial.

Authors:  Nan Zhao; Jie Zeng; Lin Fan; Jing Wang; Chao Zhang; SiHai Zou; Bi Zhang; Kai Li; Cong Yu
Journal:  Front Med (Lausanne)       Date:  2022-09-02

5.  The comparison of sedation quality, side effect and recovery profiles on different dosage of remifentanil patient-controlled sedation during breast biopsy surgery.

Authors:  Jin-Deok Joo; Jang Hyeok In; Dae-Woo Kim; Hong Soo Jung; Jae Hyeok Kang; Je Hwa Yeom; Jin Woo Choi
Journal:  Korean J Anesthesiol       Date:  2012-11-16

6.  Dexmedetomidine-remifentanil vs propofol-remifentanil for monitored anesthesia care during hysteroscopy: Randomized, single-blind, controlled trial.

Authors:  Seongjoo Park; Soo-Lyoen Choi; Francis Sahngun Nahm; Jung-Hee Ryu; Sang-Hwan Do
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.